Sign Up to like & get
recommendations!
0
Published in 2022 at "Experimental oncology"
DOI: 10.32471/exp-oncology.2312-8852.vol-44-no-2.17983
Abstract: Histone deacetylases, especially zinc-dependent deacetylases HDACs, are among attractive drug targets for treating cancer in recent years. AIM To explore the expression level of HDACs in several human cancer cell lines and examine the possible…
read more here.
Keywords:
several human;
histone deacetylases;
human cancer;
hdac ... See more keywords